201 related articles for article (PubMed ID: 34003396)
21. Chemokines and their receptors as biomarkers in esophageal cancer.
Goto M; Liu M
Esophagus; 2020 Apr; 17(2):113-121. PubMed ID: 31773415
[TBL] [Abstract][Full Text] [Related]
22. Trends in the incidence and survival of patients with esophageal cancer: A SEER database analysis.
He H; Chen N; Hou Y; Wang Z; Zhang Y; Zhang G; Fu J
Thorac Cancer; 2020 May; 11(5):1121-1128. PubMed ID: 32154652
[TBL] [Abstract][Full Text] [Related]
23. Relationship between T stage and survival in distantly metastatic esophageal cancer: A STROBE-compliant study.
Deng J; Chu X; Ren Z; Wang B
Medicine (Baltimore); 2020 May; 99(19):e20064. PubMed ID: 32384472
[TBL] [Abstract][Full Text] [Related]
24. Trends in Epidemiology of Esophageal Cancer in the US, 1975-2018.
Rodriguez GM; DePuy D; Aljehani M; Bien J; Lee JSH; Wang DH; Lin AY
JAMA Netw Open; 2023 Aug; 6(8):e2329497. PubMed ID: 37606926
[TBL] [Abstract][Full Text] [Related]
25. Dating the rise of esophageal adenocarcinoma: analysis of Connecticut Tumor Registry data, 1940-2007.
Abrams JA; Sharaiha RZ; Gonsalves L; Lightdale CJ; Neugut AI
Cancer Epidemiol Biomarkers Prev; 2011 Jan; 20(1):183-6. PubMed ID: 21127287
[TBL] [Abstract][Full Text] [Related]
26. Subjects with prostate cancer are less likely to develop esophageal cancer: analysis of SEER 9 registries database.
Cooper SC; Trudgill NJ
Cancer Causes Control; 2012 Jun; 23(6):819-25. PubMed ID: 24251326
[TBL] [Abstract][Full Text] [Related]
27. Surgery to the primary tumor is associated with improved survival of patients with metastatic esophageal cancer: propensity score-matched analyses of a large retrospective cohort.
Zhang R; Zou J; Li P; Li Q; Qiao Y; Han J; Huang K; Ruan P; Lin H; Song Q; Fu Z
Dis Esophagus; 2020 Mar; 33(3):. PubMed ID: 31175353
[TBL] [Abstract][Full Text] [Related]
28. International trends in esophageal cancer incidence rates by histological subtype (1990-2012) and prediction of the rates to 2030.
Lin Y; Wang HL; Fang K; Zheng Y; Wu J
Esophagus; 2022 Oct; 19(4):560-568. PubMed ID: 35689719
[TBL] [Abstract][Full Text] [Related]
29. A Comparative Analysis of the Gene Expression Profiles of Small Cell Esophageal Carcinoma, Small Cell Lung Cancer, and Esophageal Adeno/Squamous Carcinoma.
Liu D; Wen J; Chen J; Wang B; Xu X; Zhang Z; Fan M
Front Surg; 2021; 8():655159. PubMed ID: 34395507
[No Abstract] [Full Text] [Related]
30. Trends in esophageal cancer survival in United States adults from 1973 to 2009: A SEER database analysis.
Njei B; McCarty TR; Birk JW
J Gastroenterol Hepatol; 2016 Jun; 31(6):1141-6. PubMed ID: 26749521
[TBL] [Abstract][Full Text] [Related]
31. Nomograms to predict survival rates for esophageal cancer patients with malignant behaviors based on ICD-0-3.
Sun Y; Wang J; Li Y; Pan S; Yang T; Sun X; Wang Y; Shi X; Zhao X; Zhang X
Future Oncol; 2019 Jan; 15(2):121-132. PubMed ID: 30232909
[TBL] [Abstract][Full Text] [Related]
32. The Association Between Statin Use After Diagnosis and Mortality Risk in Patients With Esophageal Cancer: A Retrospective Cohort Study of United States Veterans.
Nguyen T; Khan A; Liu Y; El-Serag HB; Thrift AP
Am J Gastroenterol; 2018 Sep; 113(9):1310. PubMed ID: 29946180
[TBL] [Abstract][Full Text] [Related]
33. Temporal trends (1973-1997) in survival of patients with esophageal adenocarcinoma in the United States: a glimmer of hope?
Eloubeidi MA; Mason AC; Desmond RA; El-Serag HB
Am J Gastroenterol; 2003 Jul; 98(7):1627-33. PubMed ID: 12873590
[TBL] [Abstract][Full Text] [Related]
34. Incidence and Survival Changes in Patients with Esophageal Adenocarcinoma during 1984-2013.
Haiyu Z; Xiaofeng P; Xiangqiong M; Junlan Q; Xiaobin Z; Shuncong W; Huanhuan S; Haiqing M
Biomed Res Int; 2019; 2019():7431850. PubMed ID: 31915702
[TBL] [Abstract][Full Text] [Related]
35. Decreasing Black-White Disparities in Colorectal Cancer Incidence and Stage at Presentation in the United States.
May FP; Glenn BA; Crespi CM; Ponce N; Spiegel BMR; Bastani R
Cancer Epidemiol Biomarkers Prev; 2017 May; 26(5):762-768. PubMed ID: 28035021
[No Abstract] [Full Text] [Related]
36. Secular Trends in Incidence of Esophageal Cancer in Taiwan from 1985 to 2019: An Age-Period-Cohort Analysis.
Tsai MC; Chou YC; Lee YK; Hsu WL; Tang CS; Chen SY; Huang SP; Chen YC; Lee JM
Cancers (Basel); 2022 Nov; 14(23):. PubMed ID: 36497327
[TBL] [Abstract][Full Text] [Related]
37. Etiology, cancer stem cells and potential diagnostic biomarkers for esophageal cancer.
Liu K; Zhao T; Wang J; Chen Y; Zhang R; Lan X; Que J
Cancer Lett; 2019 Aug; 458():21-28. PubMed ID: 31125642
[TBL] [Abstract][Full Text] [Related]
38. Biomarkers for Early Detection, Prognosis, and Therapeutics of Esophageal Cancers.
Rai V; Abdo J; Agrawal DK
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834728
[TBL] [Abstract][Full Text] [Related]
39. Patterns and trends in esophageal cancer mortality and incidence in Europe (1980-2011) and predictions to 2015.
Castro C; Bosetti C; Malvezzi M; Bertuccio P; Levi F; Negri E; La Vecchia C; Lunet N
Ann Oncol; 2014 Jan; 25(1):283-90. PubMed ID: 24356640
[TBL] [Abstract][Full Text] [Related]
40. Impact of histology classification on pathologic treatment response and overall survival in distal esophageal cancer patients: a propensity matched analysis.
Saeed SM; Naffouje S; Mehta R; Hoffe SE; Fontaine JP; Lauwers GY; Shah P; Frakes J; Pimiento JM
Dis Esophagus; 2021 Aug; 34(8):. PubMed ID: 32996568
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
